AUTL compared with YTRA: revenue, margins and what each company keeps, and the suppliers and customers both name

AUTLAutolus Therapeutics plc

Mkt capRevenueRevenue

YTRAYatra Online, Inc.

Mkt capRevenueRevenue

Compare

AUTLAutolus Therapeutics plc

YTRAYatra Online, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

AUTL: latest quarter is a loss; flow not drawable. YTRA: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AUTL 4

MRNAModernacustomer

BNTXBioNTechcustomer

—Miltenyi Biotec GmbHunlistedsupplier

—University College of London Businessunlistedsupplier

Shared 0

No disclosed counterparties: YTRA.

Only YTRA 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

AUTL, solidYTRA, dashed

AUTLAutolus Therapeutics plc

1.51▼−4.43%· post 1.51

Mkt cap$404.6MRevenue$46MQ2 FY26Revenue$75MFY25

YTRAYatra Online, Inc.

0.80▼−3.33%· post 0.80

ClosedOct 30 '26

Mkt cap$50.6MRevenue—Revenue—

Compare

ClosedOct 30 '26

AUTLAutolus Therapeutics plc

YTRAYatra Online, Inc.

1.51▼−4.43%post 1.51

Price

0.80▼−3.33%post 0.80

$404.6M

Mkt cap

$50.6M

Q2 FY26$46M

Revenue

—

FY25$75M

Revenue

—

AUTL1.51▼−4.43%vsYTRA0.80▼−3.33%ClosedOct 30 '26